STRS Ohio’s Tango Therapeutics TNGX Stock Holding History

STRS Ohio’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$281K	Buy	+9,000	New	+$222K	﹤0.01%	1430
2024 Q2	–	Sell	-15,900	Closed	-$126K	–	2095
2024 Q1	$126K	Sell	15,900 -2,300	-13%	-$24.7K	﹤0.01%	1647
2023 Q4	$180K	Sell	18,200 -5,700	-24%	-$49.5K	﹤0.01%	1596
2023 Q3	$269K	Buy	23,900 +10,000	+72%	+$61K	﹤0.01%	1481
2023 Q2	$46K	Buy	13,900 +3,000	+28%	+$10.8K	﹤0.01%	1819
2023 Q1	$43K	Hold	10,900	–	–	﹤0.01%	1801
2022 Q4	$79K	Hold	10,900	–	–	﹤0.01%	1754
2022 Q3	$39K	Hold	10,900	–	–	﹤0.01%	1858
2022 Q2	$49K	Buy	+10,900	New	+$66K	﹤0.01%	1860

Other funds holding TNGX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

STRS Ohio's TNGX Position: Q2 2026 in Review

STRS Ohio opened a new position in Tango Therapeutics (TNGX) in Q2 2026: 9,000 shares worth $281K. The stake represents ﹤0.01% of the portfolio and ranks #1430 among its holdings. This is a return to the name: STRS Ohio previously reported a position in TNGX as recently as Q1 2024.

STRS Ohio first reported a position in TNGX in Q2 2022 and has held it in 9 quarters since. 249 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

STRS Ohio held 9,000 shares of Tango Therapeutics worth $281K as of Q2 2026.
Tango Therapeutics was a new STRS Ohio position in Q2 2026.
Tango Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #1430 holding.
STRS Ohio first reported a position in Tango Therapeutics in Q2 2022 and has held it in 9 quarters since.
249 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.